In the latest trading session, 0.47 million Atyr Pharma Inc (NASDAQ:ATYR) shares changed hands as the company’s beta touched 0.80. With the company’s most recent per share price at $3.00 changing hands around $0.15 or 5.26% at last look, the market valuation stands at $266.58M. ATYR’s current price is a discount, trading about -55.33% off its 52-week high of $4.66. The share price had its 52-week low at $1.42, which suggests the last value was 52.67% up since then. When we look at Atyr Pharma Inc’s average trading volume, we note the 10-day average is 1.48 million shares, with the 3-month average coming to 1.35 million.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Instantly ATYR is in green as seen in intraday trades today. With action 4.17%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -17.13%, with the 5-day performance at 4.17% in the green. However, in the 30-day time frame, Atyr Pharma Inc (NASDAQ:ATYR) is -3.23% down. Looking at the short shares, we see there were 6.92 million shares sold at short interest cover period of 3.39 days.
Atyr Pharma Inc (ATYR) estimates and forecasts
Year-over-year growth is forecast to reach 751.06% up from the last financial year.
The company’s revenue for the corresponding quarters a year ago was 235k. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -100.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 34.28%. The 2025 estimates are for Atyr Pharma Inc earnings to increase by 17.86%.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.24% of Atyr Pharma Inc shares while 61.92% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 63.33%.
Among Mutual Funds, the top two as of Jan 31, 2025 were Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund. With 7.85 shares estimated at $23.04 million under it, the former controlled 8.83% of total outstanding shares. On the other hand, Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund held about 7.45% of the shares, roughly 6.62 shares worth around $19.43 million.
